Cubist Systematic Strategies’s Co-Diagnostics CODX Stock Holding History

Cubist Systematic Strategies’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,849	Closed	-$311K	–	4455
2022 Q2	$311K	Sell	1,849 -108	-6%	-$16.4K	﹤0.01%	3411
2022 Q1	$363K	Sell	1,957 -2,104	-52%	-$436K	﹤0.01%	2728
2021 Q4	$1.09M	Buy	4,061 +1,527	+60%	+$401K	0.01%	1849
2021 Q3	$740K	Sell	2,534 -391	-13%	-$114K	0.01%	1753
2021 Q2	$724K	Buy	2,925 +2,212	+310%	+$569K	0.01%	1777
2021 Q1	$204K	Buy	713 +188	+36%	+$75K	﹤0.01%	2464
2020 Q4	$146K	Buy	+525	New	+$195K	﹤0.01%	2345
2020 Q3	–	Sell	-917	Closed	-$532K	–	2503
2020 Q2	$532K	Buy	+917	New	+$419K	0.01%	1558

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cubist Systematic Strategies's CODX Position: Q3 2022 in Review

Cubist Systematic Strategies sold out of Co-Diagnostics (CODX) in Q3 2022, closing a stake of 1,849 shares — an estimated $311K sold.

Cubist Systematic Strategies first reported a position in CODX in Q2 2020 and held it in 8 quarters. The position peaked at $1.09M in Q4 2021. 65 funds tracked by Wall St. Rank hold CODX as of Q3 2022.

Cubist Systematic Strategies reported no remaining Co-Diagnostics position as of Q3 2022 after selling out during the quarter.
Cubist Systematic Strategies sold 1,849 Co-Diagnostics shares in Q3 2022, an estimated $311K.
Cubist Systematic Strategies first reported a position in Co-Diagnostics in Q2 2020 and held it in 8 quarters.
Cubist Systematic Strategies's Co-Diagnostics position peaked at $1.09M in Q4 2021.
65 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2022.

Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.